Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S.-Australia Trade Pact Lacks Language Banning Drug Exportation

Executive Summary

Language prohibiting Australia's export of certain drugs to the U.S. was stricken from a bilateral free trade agreement because it was "unnecessary," Assistant U.S. Trade Rep. Ralph Ives said March 12

You may also be interested in...



U.S.-Australia Rx “Transparency” Deal Applies To Medicare Part B

Medicare Part B drug reimbursement decisions will be subject to the transparency provisions of the U.S.-Australia Free Trade Agreement, the U.S. Trade Representative says

Rx Import Laws Would Not Be Blocked By Australia Trade Deal, USTR Says

The U.S.-Australia free trade agreement moving through Congress underscores the right of manufacturers to control resale of their products across national borders

U.S.-Australia Rx “Transparency” Deal Applies To Medicare Part B

Medicare Part B drug reimbursement decisions will be subject to the transparency provisions of the U.S.-Australia Free Trade Agreement, the U.S. Trade Representative says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel